ns 1619 has been researched along with monocrotaline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandes, RP; Hofstetter, C; Kirschning, T; Neofitidou, S; Revermann, M; Schloss, M | 1 |
1 other study(ies) available for ns 1619 and monocrotaline
Article | Year |
---|---|
Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension.
Topics: Administration, Inhalation; Animals; Becaplermin; Benzimidazoles; Blotting, Western; Cell Proliferation; Cells, Cultured; Hemodynamics; Hypertension, Pulmonary; Large-Conductance Calcium-Activated Potassium Channels; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Monocrotaline; Myocytes, Smooth Muscle; Oxygen; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Ventricular Dysfunction, Right; Ventricular Pressure | 2014 |